Beauty Health Company (The) OverviewBeauty Health Company (The)'s EBIT is $-220M, below the Healthcare sector average of $23B.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2021
Trailing 12 months ending Sep 30, 2021
As of the most recent data (September 2021), SKIN shows a EBIT of $-220M. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.
The Healthcare sector average EBIT is about $23B. Beauty Health Company (The) is at $-220M, which is lower that average. That is roughly 101.0% below the sector mean. Use the comparison chart on this page to see how SKIN stacks up against individual peers as well.
Tracking SKIN's ebit over time shows whether Beauty Health Company (The) is scaling, shrinking, or reshaping that part of the business. The current reading is $-220M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Beauty Health Company (The)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-220M) with ownership activity and broader fundamentals.
The Healthcare average EBIT is about $23B, while SKIN is at $-220M. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
